ArticleCancer immunology research2015

T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression.

Stephen P Santoro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.